看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM P/E Multiple | 24.2x - 26.8x | 25.5x |
| Selected Fwd P/E Multiple | 22.1x - 24.4x | 23.3x |
| Fair Value | £3.65 - £4.04 | £3.85 |
| Upside | -2.6% - 7.7% | 2.6% |
| Benchmarks | - | Full Ticker |
| NIOX Group Plc | - | AIM:NIOX |
| Advanced Medical Solutions Group plc | - | AIM:AMS |
| Surgical Innovations Group plc | - | AIM:SUN |
| ConvaTec Group PLC | - | LSE:CTEC |
| Creo Medical Group PLC | - | AIM:CREO |
| Tristel plc | - | AIM:TSTL |
| - | - | - |
| Select Price / LTM EPS Ratio | ||||||||
| Benchmark Companies | ||||||||
| NIOX | AMS | SUN | CTEC | CREO | TSTL | |||
| AIM:NIOX | AIM:AMS | AIM:SUN | LSE:CTEC | AIM:CREO | AIM:TSTL | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | NM- | -17.8% | NM- | 81.0% | NM- | 10.0% | ||
| 3Y CAGR | 13.9% | -26.0% | NM- | 17.4% | NM- | 21.1% | ||
| Latest Twelve Months | -64.2% | -55.4% | -281.7% | 46.2% | -17.3% | 1.7% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | -18.2% | 13.1% | -15.4% | 5.0% | -19929.7% | 11.6% | ||
| Prior Fiscal Year | 25.8% | 12.6% | -4.2% | 6.1% | -592.5% | 12.4% | ||
| Latest Fiscal Year | 8.1% | 4.0% | -16.3% | 8.3% | -695.0% | 15.5% | ||
| Latest Twelve Months | 8.1% | 4.0% | -16.3% | 8.3% | -695.0% | 14.1% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | 25.2x | 22.4x | -20.3x | 14.7x | -1.9x | 18.4x | ||
| Price / LTM Sales | 6.9x | 2.5x | 0.5x | 2.9x | 14.1x | 4.1x | ||
| LTM P/E Ratio | 84.2x | 61.8x | -3.4x | 34.4x | -2.0x | 29.2x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/E Ratio | -3.4x | 34.4x | 84.2x | |||||
| Historical LTM P/E Ratio | -733.3x | 39.5x | 72.9x | |||||
| Selected P/E Multiple | 24.2x | 25.5x | 26.8x | |||||
| (x) LTM Net Income | 6 | 6 | 6 | |||||
| (=) Equity Value | 149 | 156 | 164 | |||||
| (/) Shares Outstanding | 47.7 | 47.7 | 47.7 | |||||
| Implied Value Range | 3.12 | 3.28 | 3.44 | |||||
| FX Rate: GBP/GBP | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 3.12 | 3.28 | 3.44 | 3.75 | ||||
| Upside / (Downside) | -16.9% | -12.6% | -8.2% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | NIOX | AMS | SUN | CTEC | CREO | TSTL | |
| Value of Common Equity | 286 | 438 | 7 | 6,517 | 56 | 179 | |
| (/) Shares Outstanding | 417.6 | 215.4 | 932.8 | 2,044.3 | 402.5 | 47.7 | |
| Implied Stock Price | 0.69 | 2.04 | 0.01 | 3.19 | 0.14 | 3.75 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.33 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 0.69 | 2.04 | 0.01 | 2.39 | 0.14 | 3.75 | |
| Trading Currency | GBP | GBP | GBP | GBP | GBP | GBP | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.33 | 1.00 | 1.00 | |